Association of GLP-1 receptor agonist use with psychiatric outcomes in adults with type 2 diabetes: a target trial emulation. [PDF]
Diabetes Res Clin PractTang H +9 more
europepmc +1 more source
Response to the Letter to the Editor for "Association of GLP-1 Receptor Agonist Use With Risk of Lumbar Degenerative Disease and Spine Surgery in Patients With Type 2 Diabetes: A Propensity Score-Matched Cohort Study". [PDF]
Global Spine JChang Y, Lin HM, Chen CM.
europepmc +1 more source
Prevalence and Factors Associated with GLP-1 Receptor Agonist Use for Weight Management Among Overweight and Obese Adults in the Eastern Province of Saudi Arabia. [PDF]
Healthcare (Basel)Alhussain K +5 more
europepmc +1 more source
Real-world treatment trajectories preceding GLP-1 receptor agonist initiation in type 2 diabetes: A descriptive UK population-based cohort study on adherence to national clinical guidelines. [PDF]
Diabetes Obes MetabUlrich FS +3 more
europepmc +1 more source
Neurobeachin (NBEA) is a novel gene associated with GLP-1 receptor agonist associated weight loss. [PDF]
Diabetes Obes MetabMariam-Smith A +6 more
europepmc +1 more source
Should GLP-1 receptor agonist therapy be used to treat obesity in Bardet-Biedl syndrome? [PDF]
J Clin InvestTomlinson JW.
europepmc +1 more source
Factors Associated with GLP-1 Receptor Agonist Use in Patients with Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Retrospective Propensity-Score Matched Analysis. [PDF]
DiseasesVournas G +5 more
europepmc +1 more source
Signals arising from the gastrointestinal tract that affect food intake (Syömiseen vaikuttavat mahasuolikanavan signaalit) [PDF]
Purhonen, Anna-Kaisa
core